197 related articles for article (PubMed ID: 37067675)
1. Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.
Yang F; Zheng X; Koh S; Lu J; Cheng J; Li P; Du C; Chen Y; Chen X; Yang L; Chen W; Wong RW; Wai LE; Wang T; Zhang Q; Chen W
Hepatol Int; 2023 Aug; 17(4):850-859. PubMed ID: 37067675
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial.
Meng F; Zhao J; Tan AT; Hu W; Wang SY; Jin J; Wu J; Li Y; Shi L; Fu JL; Yu S; Shen Y; Liu L; Luan J; Shi M; Xie Y; Zhou CB; Wong RW; Lu-En W; Koh S; Bertoletti A; Wang T; Zhang JY; Wang FS
Hepatol Int; 2021 Dec; 15(6):1402-1412. PubMed ID: 34850325
[TBL] [Abstract][Full Text] [Related]
3. Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Tan AT; Yang N; Lee Krishnamoorthy T; Oei V; Chua A; Zhao X; Tan HS; Chia A; Le Bert N; Low D; Tan HK; Kumar R; Irani FG; Ho ZZ; Zhang Q; Guccione E; Wai LE; Koh S; Hwang W; Chow WC; Bertoletti A
Gastroenterology; 2019 May; 156(6):1862-1876.e9. PubMed ID: 30711630
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive Drug-Resistant Armored T-Cell Receptor T Cells for Immune Therapy of HCC in Liver Transplant Patients.
Hafezi M; Lin M; Chia A; Chua A; Ho ZZ; Fam R; Tan D; Aw J; Pavesi A; Krishnamoorthy TL; Chow WC; Chen W; Zhang Q; Wai LE; Koh S; Tan AT; Bertoletti A
Hepatology; 2021 Jul; 74(1):200-213. PubMed ID: 33249625
[TBL] [Abstract][Full Text] [Related]
5. Evolution of expression of hepatitis B surface and core antigens (HBsAg, HBcAg) in resected primary and recurrent hepatocellular carcinoma in HBsAg carriers in Taiwan. Correlation with local host immune response.
Hsu HC; Wu TT; Wu MZ; Wu CY; Chiou TJ; Sheu JC; Lee CS; Chen DS
Cancer; 1988 Sep; 62(5):915-21. PubMed ID: 2842026
[TBL] [Abstract][Full Text] [Related]
6. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
[TBL] [Abstract][Full Text] [Related]
7. Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC.
Tan AT; Meng F; Jin J; Zhang JY; Wang SY; Shi L; Shi M; Li Y; Xie Y; Liu LM; Zhou CB; Chua A; Ho ZZ; Luan J; Zhao J; Li J; Wai LE; Koh S; Wang T; Bertoletti A; Wang FS
Hepatol Commun; 2022 Apr; 6(4):841-854. PubMed ID: 34935312
[TBL] [Abstract][Full Text] [Related]
8. In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinoma.
Liu Q; Tian Y; Li Y; Zhang W; Cai W; Liu Y; Ren Y; Liang Z; Zhou P; Zhang Y; Bao Y; Li Y
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33323464
[TBL] [Abstract][Full Text] [Related]
9. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post-liver transplantation and resection.
Schemmer P; Burra P; Hu RH; Hüber CM; Loinaz C; Machida K; Vogel A; Samuel D
Liver Int; 2022 Feb; 42(2):288-298. PubMed ID: 34846790
[TBL] [Abstract][Full Text] [Related]
10. Post-transplant hepatitis B virus reactivation impacts the prognosis of patients with hepatitis B-related hepatocellular carcinoma: a dual-centre retrospective cohort study in China.
Li H; Lu D; Chen J; Zhang J; Zhuo J; Lin Z; Cao C; Shen W; He C; Chen H; Hu Z; Sun Y; Wei X; Zhuang L; Zheng S; Xu X
Int J Surg; 2024 Apr; 110(4):2263-2274. PubMed ID: 38348848
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
[TBL] [Abstract][Full Text] [Related]
13. The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.
Lu D; Yang F; Zhuo J; Yang M; Lin Z; Jin P; Cai X; Cen B; Wang J; Wei X; Zheng S; Xu X
Clin Transl Gastroenterol; 2020 May; 11(5):e00168. PubMed ID: 32358239
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes transiently expressing virus-specific T cell receptors reduce hepatitis B virus infection.
Kah J; Koh S; Volz T; Ceccarello E; Allweiss L; Lütgehetmann M; Bertoletti A; Dandri M
J Clin Invest; 2017 Aug; 127(8):3177-3188. PubMed ID: 28737510
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient.
Qasim W; Brunetto M; Gehring AJ; Xue SA; Schurich A; Khakpoor A; Zhan H; Ciccorossi P; Gilmour K; Cavallone D; Moriconi F; Farzhenah F; Mazzoni A; Chan L; Morris E; Thrasher A; Maini MK; Bonino F; Stauss H; Bertoletti A
J Hepatol; 2015 Feb; 62(2):486-91. PubMed ID: 25308176
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome.
Wu TJ; Chan KM; Chou HS; Lee CF; Wu TH; Chen TC; Yeh CT; Lee WC
Ann Surg Oncol; 2013 Oct; 20(11):3582-90. PubMed ID: 23760589
[TBL] [Abstract][Full Text] [Related]
19. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Yoo S; Kim JY; Lim YS; Han S; Choi J
J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
[TBL] [Abstract][Full Text] [Related]
20. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines.
Gehring AJ; Xue SA; Ho ZZ; Teoh D; Ruedl C; Chia A; Koh S; Lim SG; Maini MK; Stauss H; Bertoletti A
J Hepatol; 2011 Jul; 55(1):103-10. PubMed ID: 21145860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]